A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase InhibitorsYing Jin, Peihua Luo|Frontiers in Pharmacology|2020Cited by 80
Inhibition of PRKAA/AMPK (Ser485/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusionZhifei Xu, Peihua Luo|Autophagy|2023Cited by 56
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamidePeihua Luo, Qiaojun He|Cell Research|2020Cited by 44
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axisHao Yan, Peihua Luo|Nature Communications|2023Cited by 39
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XLHao Yan, Peihua Luo|Advanced Science|2023Cited by 13